160 related articles for article (PubMed ID: 3901702)
1. [Prostatic tissue levels of ceftizoxime].
Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
[TBL] [Abstract][Full Text] [Related]
2. [Serum and prostatic tissue concentration of ceftizoxime (CZX) after intravenous administration in cases of benign prostatic hypertrophy].
Wakatsuki A; Nishio S; Morita M; Takeuchi M; Murase M
Hinyokika Kiyo; 1985 Nov; 31(11):2080-4. PubMed ID: 2418663
[TBL] [Abstract][Full Text] [Related]
3. [A study on transfer of ceftizoxime into prostatic and vesical tissues].
Katsumi T; Murayama K
Hinyokika Kiyo; 1984 Feb; 30(2):259-64. PubMed ID: 6204521
[TBL] [Abstract][Full Text] [Related]
4. [Transfer of ceftizoxime into serum and prostatic tissue].
Fujisawa M; Mizunaga M; Arima S; Tokunaka S; Inada F; Takamura T; Yachiku S
Hinyokika Kiyo; 1985 Oct; 31(10):1855-9. PubMed ID: 2418658
[TBL] [Abstract][Full Text] [Related]
5. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
Ikeda S; Ishibashi A; Koshiba K
Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
[TBL] [Abstract][Full Text] [Related]
6. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
[TBL] [Abstract][Full Text] [Related]
7. [Study on the prostatic tissue levels of cefmenoxime (CMX)].
Kataoka K; Kaneko S; Kurita T
Hinyokika Kiyo; 1985 Feb; 31(2):273-9. PubMed ID: 2409786
[TBL] [Abstract][Full Text] [Related]
8. [Experimental and clinical studies on ceftizoxime in the field of oral surgery (author's transl)].
Tsushima T; Tsuto H; Minami Y; Yamamoto T; Ueda K; Morihana T; Nagata K; Nakao K; Shimada K
Jpn J Antibiot; 1982 Feb; 35(2):399-408. PubMed ID: 6283194
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory and clinical studies on ceftizoxime (author's transl)].
Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Kotani Y; Takagi M
Jpn J Antibiot; 1982 Jan; 35(1):69-80. PubMed ID: 6279914
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and clinical studies on ceftizoxime in otorhinolaryngological field (author's transl)].
Hatano T; Baba S; Hondoh J; Wada K; Murai K; Kinoshita H; Itoh H; Suzuki Y; Maruo T
Jpn J Antibiot; 1981 Dec; 34(12):1571-82. PubMed ID: 6278177
[TBL] [Abstract][Full Text] [Related]
11. [Clinical laboratory approach for estimating effective administrative dose of ceftizoxime. Observation from MIC and ceftizoxime disc susceptibility test].
Uete T; Matsuo K
Jpn J Antibiot; 1987 Feb; 40(2):331-9. PubMed ID: 3474430
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory and clinical studies of ceftizoxime in pediatrics (author's transl)].
Sekiguchi T; Miyao M; Kokawa T; Yuasa Y; Uyama Y; Tanaka H
Jpn J Antibiot; 1982 Jan; 35(1):160-70. PubMed ID: 6279907
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of ceftizoxime suppositories in acute suppurative otitis media in children and tissue concentration of ceftizoxime in the palatine tonsil after administration of ceftizoxime suppositories].
Kinoshita H; Baba S; Mori Y; Suzuki K; Shimada J; Maruo T; Ito H
Jpn J Antibiot; 1985 Oct; 38(10):3070-6. PubMed ID: 3866093
[TBL] [Abstract][Full Text] [Related]
14. [Fundamental and clinical studies of ceftizoxime suppositories in the pediatric field].
Sato Y; Iwata S; Akita H; Murai T; Ihara M; Oikawa T; Osano M
Jpn J Antibiot; 1985 Oct; 38(10):2877-88. PubMed ID: 3908728
[TBL] [Abstract][Full Text] [Related]
15. [Prostatic tissue levels of cefpiramide (CPM)].
Takata K; Kawamura S; Yoshida I
Hinyokika Kiyo; 1988 Jun; 34(6):1105-8. PubMed ID: 2464916
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effect of ceftizoxime on infections in aged patients].
Horiuchi I; Kawamoto T; Tokumo H; Nomura Y; Kajiyama G; Oobayashi M; Matsui Y; Nakagawa K; Nakamura M; Daitoku K
Jpn J Antibiot; 1986 Jul; 39(7):1671-80. PubMed ID: 3464771
[TBL] [Abstract][Full Text] [Related]
17. [Clinical investigation of ceftizoxime sodium suppositories in pediatric infections].
Tomimasu K; Hayashi K; Tsuji Y
Jpn J Antibiot; 1985 Oct; 38(10):3065-9. PubMed ID: 3908730
[TBL] [Abstract][Full Text] [Related]
18. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
Takao M; Matsuzaki S; Ao T; Nagakura K; Fujioka T; Hata M; Nakamura H; Hayakawa M
Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116
[TBL] [Abstract][Full Text] [Related]
19. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
[TBL] [Abstract][Full Text] [Related]
20. [Clinical investigation of ceftizoxime sodium suppositories in the field of pediatrics].
Sato T; Ueda K; Kuroiwa T
Jpn J Antibiot; 1985 Oct; 38(10):3057-64. PubMed ID: 3866092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
